Table 2.
Publication | Amino acid substitutions | Pregnancy duration | Age on onset | Age of death | Alive at | Riboflavin therapy | Neurological symptoms | Brain abnormalities | Seizures | Psychiomotor dev. delay | Hypotonia | Hearing loss | Respiratory problems | Tachypnea | Dyspnoea | Respiratory disturbance | Other organ failure | Hyperthrophic cardiomyopathy | Hepatomology | Other | Failure to thrive | Exercise intolerance | Short stature |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nouws et al. 2010 | Arg518His (I-1) | Term | 8 m | 18 y | – | – | – | – | + | + | – | – | + | + | + | + | + | ||||||
Glu63X and Glu413Lys (II-1) | 35 | 4 m | 6 m | + | – | + | + | ||||||||||||||||
Haack et al. 2010 | Phe44Ile and Arg266Gln (I:A) | 39 w + 6 d | 24 h | 46 d | + | + | – | + | + | + | – | – | |||||||||||
Phe44Ile and Arg266Gln (I:B) | Birth | 5 y | + | + | – | – | + | – | + | ||||||||||||||
Arg266Gln and Arg417Cys (II) | Birth | 12 y | – | – | + | – | – | ||||||||||||||||
Ala326Pro and Arg532Trp (III) | Birth | 2 y | + | – | + | + | – | ||||||||||||||||
Gerards et al. 2011, Scholte et al. 1995 |
Arg532Trp (VII-6) | 4 y | 31 y | + | – | – | – | – | – | – | + | + | |||||||||||
Arg532Trp (VII-8) | 4 y | 38 y | + | – | + | v | – | – | – | – | + | ||||||||||||
Arg532Trp (VII-11) | 4y | 40 y | + | – | + | – | – | – | – | – | + | ||||||||||||
Arg127Gln and Arg469Trp (CV) | Early CH | 27 y | + | – | – | – | – | + | – | – | – | + | |||||||||||
Haack et al. 2012 | Arg532Trp (59029) | + | + | + | |||||||||||||||||||
Arg532Trp (59033) | + | + | + | ||||||||||||||||||||
Arg532Trp (59036) | + | + | + | ||||||||||||||||||||
This report | Ala220Val | 41 w + 4 d | Birth | 6 m | – | – | – | + | + | + | + | + | + | + | – |
Dev. developmental, + symptom present, – symptom absent, empty box if information is not available, CH childhood, d days, w weeks, m months, y years